Financials

  • Market Capitalization 14 B
  • Employee 1 077
  • Founded 1994
  • CEO Michael M. Morrissey
  • Website www.exelixis.com
  • Headquarter Delaware, United States
  • FIGI BBG000BQ4WF8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
15.68
Price to sales ratio
5.29

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
666
BBIO
BridgeBio Pharma, Inc. - Common Stock
82.16 USD-4.34%+4.50%+21.59%+44.14%16.09 B USD
708
JAZZ
Jazz Pharmaceuticals plc - Ordinary Shares
237.32 USD-2.67%-2.71%+0.80%+69.51%14.89 B USD
810
MDGL
Madrigal Pharmaceuticals, Inc. - Common Stock
532.39 USD-0.80%-0.64%+12.25%+25.68%12.27 B USD
823
SMMT
Summit Therapeutics Inc. - Common Stock
15.26 USD+0.07%-2.80%+17.38%-23.16%11.84 B USD

Frequently asked questions about Exelixis, Inc. - Common Stock

What is the Exelixis, Inc. - Common Stock stock price today?

The current price of Exelixis, Inc. - Common Stock (EXEL) is 55.7. Over the past 24 hours, the stock has changed by -1.42%. Follow the EXEL chart for real-time price dynamics.

What is the stock ticker of Exelixis, Inc. - Common Stock?

Exelixis, Inc. - Common Stock trades under the ticker EXEL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Exelixis, Inc. - Common Stock stock going up?

EXEL has changed by +0.27% over the last week, +4.11% over the last month, and +42.67% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Exelixis, Inc. - Common Stock have?

As of the latest available data, Exelixis, Inc. - Common Stock has 1 077 employees. Workforce size can provide additional context about the company's scale and operations.

What is Exelixis, Inc. - Common Stock EBITDA?

Exelixis, Inc. - Common Stock EBITDA is 258.29 M, and its EBITDA margin is 42.29%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Exelixis, Inc. - Common Stock stock?

You can buy Exelixis, Inc. - Common Stock (EXEL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Exelixis, Inc. - Common Stock stock?

Investing in Exelixis, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EXEL chart and related analysis on metatrader.com as part of your research.

Exelixis, Inc. - Common Stock

Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.

News